The Director General of the National Agency for Food and Drug Administration and Control (NAFDAC), Professor Moji Adeyeye, has appealed to stakeholders and key players in the pharmaceutical sector to adhere to the agency’s vision of ensuring the availability of quality medications for Nigerians.
This appeal was made during the official launch of the ultra-modern wholesale and distribution center for regulated medicines established by New Heights Pharmaceuticals.
Professor Adeyeye commended the company for aligning with NAFDAC’s vision, which aims to provide trustworthy medicines for Nigerians. She emphasized that the center’s establishment resonates with NAFDAC’s goal of traceability, ensuring that drugs and medicines can be traced to authentic and certified manufacturers and distributors nationwide. This, in turn, enhances confidence among caregivers and patients regarding the medications they use. Professor Adeyeye expressed belief that Nigeria can achieve similar standards as other parts of the world.
Join Our WhatsApp Channel for Exclusive Stories, News Reports, and Engaging Content. {Click Here}
Babashehu Ahmed, the Registrar of the Pharmacists Council of Nigeria (PCN), stated that the new center’s inauguration will accelerate NAFDAC’s efforts to combat illegal drug distribution networks within the state. Represented by Ukamaka Okafor, the PCN Coordinator for the Lagos Office, Ahmed highlighted the successful implementation of the National Drug Distribution Guidelines in Kano State and emphasized the alignment of the center’s opening with this objective.
Pharmacist Ogheneochuko Omaruaye urged NAFDAC and the PCN to expedite the implementation of the National Drug Distribution Guidelines in Lagos. He recounted the challenges faced by retail pharmacy stores over two decades ago in sourcing quality healthcare products for their clients. He praised New Heights Pharmaceuticals for establishing a world-class pharmaceutical healthcare space in Nigeria, inspired by a similar facility in the UK, and emphasized the importance of this initiative in addressing the issues of falsified and substandard medicines.
The Chairman of the Board of Directors, Paul Enebeli, called on the Federal government to support the company in replicating similar centers across the country’s six geopolitical zones.
